Search
AxoGen Inc
AXGNAdd to Watchlist
44.020USD
-2.170-4.70%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
2.08BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-4.70%
5 Days
+3.53%
1 Month
+13.69%
6 Months
+34.49%
Year to Date
+34.49%
1 Year
+301.64%
Key Figures
46.360Open
46.950High
1.40MVolume
LossP/E TTM
51.59P/E Dynamic
--Dividend TTM
2.97%Turnover Ratio
46.190Prev. Close
43.850Low
49.63MTurnover
LossP/E Static
16.13P/B
0.00%Div Yield TTM
-12.95%ROA
45.83052wk High
0.74Volume Ratio
-9.96MNet Profit
47.20MShares
-0.6358EPS TTM
1.14Beta
-17.96%ROE
9.21552wk Low
6.71%Amplitude
75.16%Gross Margin
2.08BMarket Cap
5.68Reward/Risk
3.00%Risk Rate
TradingKey Stock Score of AxoGen Inc
Currency: USD Updated: 2026-06-30Key Insights
AxoGen Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 9 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 50.70.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
AxoGen Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
AxoGen Inc Highlights
StrengthsRisks
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 41.63% year-on-year.
Fairly Valued
The company’s latest PE is -72.65, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 48.71M shares, increasing 6.07% quarter-over-quarter.
Held by Ron Baron
Star Investor Ron Baron holds 534.99K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.73.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
50.700
Target Price
+9.76%
Upside Space
AxoGen Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
AxoGen Inc Info
Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.
Ticker SymbolAXGN
CompanyAxoGen Inc
CEODale (Michael Donald)
Websitehttps://www.axogeninc.com/
Related Instruments
+2.62%
+2.41%
+1.57%
+1.18%
+1.73%
+1.30%
-0.50%
+1.27%
+7.60%
+0.88%
+0.39%
+0.89%
+1.92%
+1.70%
+3.09%
+2.12%
+1.08%
+1.78%
+0.41%
+0.78%Popular Instruments
FAQs
What is the current price of AxoGen Inc (AXGN)?
The current price of AxoGen Inc (AXGN) is 44.02.
What is the symbol of AxoGen Inc?
The ticker symbol of AxoGen Inc is AXGN.
What is the 52-week high of AxoGen Inc?
The 52-week high of AxoGen Inc is 45.83.
What is the 52-week low of AxoGen Inc?
The 52-week low of AxoGen Inc is 9.21.
What is the market capitalization of AxoGen Inc?
The market capitalization of AxoGen Inc is 2.08B.
Is AxoGen Inc (AXGN) currently rated as Buy, Hold, or Sell?
According to analysts, AxoGen Inc (AXGN) has an overall rating of Buy, with a price target of 50.70.
What is the Earnings Per Share (EPS TTM) of AxoGen Inc (AXGN)?
The Earnings Per Share (EPS TTM) of AxoGen Inc (AXGN) is -0.34.